Moderna buried child's death in COVID booster trial in EU report, FDA response called 'misleading'
President Joe Biden bestowed the National Medal of Technology and Innovation on a vaccine maker that allegedly hid a child's death in a COVID-19 clinical trial from Americans, and the Food and Drug Administration may have known about the purported subterfuge.
Northwestern sues Moderna for patent infringement over COVID-19 vaccines
Oct 16 (Reuters) - Moderna (MRNA.O) was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused the company of misusing the school's innovations to develop its blockbuster COVID-19 vaccine Spikevax. The lawsuit said Moderna uses Northwestern-developed lipid nanoparticle (LNP) technology without a license in Spikevax shots to transport fragile messenger RNA into the human body. A Moderna spokesperson said the company was aware of the lawsuit and will defend itself against the claims.
US awards Moderna $176 million to produce bird flu vaccine
The U.S. government has awarded $176 million to Moderna (MRNA.O), opens new tab to advance development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three dairy workers since March.
Shares of the Cambridge, Massachusetts-based company rose more than 2% to $118.32 in early trade.
Moderna says its combination Covid and flu vaccine works well in late-stage trial
Moderna said on Monday its combination vaccine to protect against both Covid and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots against the viruses in a late-stage trial.
In the study, the combination using messenger RNA technology generated greater antibodies than currently marketed traditional flu vaccines and Moderna’s Spikevax mRNA Covid shot, the company said.
Experimental mRNA vaccines gain steam with promising cancer trial results
Pharmaceutical giants Moderna and Merck announced promising results from a clinical trial testing a combined treatment of an mRNA vaccine and immunotherapy for skin cancer. Melanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower chances of cancer recurrence and spread, as well as higher survival rates, than those who received Keytruda alone.
Moderna says FDA delayed RSV vaccine approval to end of May
Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency.
The FDA was expected to make a decision on the RSV shot on Sunday. The agency has not informed Moderna of any issues related to the vaccine’s safety, efficacy or quality that would prevent its approval, the biotech company said in a release.
Moderna CEO says AI will help scientists understand ‘most diseases’ in 3 to 5 years
Moderna CEO Stéphane Bancel said Thursday that with the help of AI scientists will likely “understand most diseases” in the next three to five years, in what will be a “first for humans on the planet.”
“If you understand the disease, you will find a way to go fix it,” Bancel said at Semafor’s World Economy Summit. “The reason we still have people dying of cancer, people suffering from Alzheimers, is we do not understand the fundamental biology of those diseases.”
The CDC just killed another right-wing Covid vaccine conspiracy theory
A new study out of the U.S. Centers for Disease Control and Prevention dispels a popular coronavirus-related conspiracy theory that’s been popular among right-wingers. For a while now, anti-vaxxers have pointed to highly publicized incidents of people — particularly, young people — suffering cardiac arrest and concluded that their conditions must have been caused by the Covid-19 mRNA vaccine. Several Fox News hosts, for example, tried to blame the vaccine for LeBron James Jr.'s suffering a cardiac arrest last summer.
Moderna halts vaccine plant in Africa amid dwindling orders
Moderna has paused its efforts to build an mRNA manufacturing facility in Kenya while it determines future demand for COVID-19 vaccines on the African continent, the firm said in a statement Thursday. Moderna’s plan was part of efforts to widen access to vaccines that have remained out of reach to large parts of the world. Africa has been trying to reduce the continent’s reliance on the rest of the world for vaccine supplies. Demand for COVID-19 vaccines in Africa has declined since the pandemic and is too little to support...
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
Moderna has more to offer beyond its Covid vaccine.
The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against other viruses. The company is moving those shots to final stage studies, it said.